Drreddys Laboratories | RDY - Betriebsaufwand





Betriebsaufwand Veränderung Datum
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bayer EUR 10.04B 168M 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Cipla INR 62.31B 3.04B 2026-06
Corcept Therapeutics USD 214.85M 343K 2026-06
Drreddys Laboratories INR 74.33B 1.4B 2026-03
GlaxoSmithKline GBP 5.8B 468M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Novartis USD 10.2B 912M 2026-06
Pacira USD 180.54M 7.79M 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 213.19M 7.06M 2026-06
Richter Gedeon HUF 157.88B 6.77B 2026-03
Sun Pharmaceuticals INR 117.43B 648.5M 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06